Replies to post #3797 on Theralase Technologies Inc (TLTFF)

[citoyen]

-3 Have now read most of what's on stockhouse, including latest re new company Lumeda. Not yet clear how this might affect TLT...whether a positive or negative for them. More PDT interest is good on the surface but also means more competition. Lumeda seems like a possible new user for 1433, but questions remain about patents or new PDT companies finding workarounds or new/better PDT treatments and new indications that TLT intended to pursue. meanwhile, dwindling $$ at TLT as we await resumption of clinicals. Without news of serious progress, TLT would not do well if more capital required.

Lots of questions...and unfortunately no one at company who is willing -- or perhaps able -- to communicate re the above and other important matters with any consistency or transparency.

Realize it can't be easy for TLT and so many other small companies in analogous financial circumstances, but again, company does itself no favors with its deafening silence...